Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 355-359

  Nosanchuk, J D ^a,c   Sepkowitz, K A ^a,b   Pearse, R N ^a   White, M H ^a   Nimer, S D ^a   Armstrong, D ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Autologous transplants; Infection; Leukemia; Lymphoma

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ACICLOVIR; AMPHOTERICIN B; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; GENTAMICIN; GROWTH FACTOR; MITOXANTRONE; NORFLOXACIN; NYSTATIN; TIMENTIN;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTERIAL INFECTION; FATALITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTIOUS COMPLICATION; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MYCOSIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; VIRUS INFECTION;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFECTION; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029814791     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Nemunatis J. Growth factors in allogeneic transplantation. Semin Oncol 1993; 20 (Suppl. 6): 96-101.
2. Hiemenz JW, Greene JN. Special considerations for the patient undergoing allogeneic or autologous bone marrow transplantation. Hematol Oncol Clin North Am 1993; 7: 961-1002.
3. Winston DJ, Gale RP, Meyer DV et al. Infectious complications of human bone marrow transplantation. Medicine 1979; 58: 1-31.
4. Peterson PK, Ramsay NKC, Rhame F et al. A prospective study of infectious diseases following bone marrow transplantation. Infect Control 1983; 4: 81-89.
5. Meyers JD. Infection in bone marrow transplant recipients. Am J Med 1986; 81: 27-38.
6. Watson JG. Problems of infection after bone marrow transplantation. J Clin Palhol 1983; 36: 683-692.
7. Paulin T, Ringden O, Nilsson B et al. Variables predicting bacterial and fungal infections after allogenic marrow engraftment. Transplantation 1987, 43: 393-398.
8. Kirk JL Jr, Greenfield RA, Slease RB, Epstein RB. Analysis of early infectious complications after bone marrow transplant. Cancer 1988; 62: 2445-2450.
9. Vose JM, Kennedy BC, Bierman PJ et al. Long term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 1992; 69: 784-789.
10. Wingard JR. Infections in allogeneic bone marrow transplant recipients. Semin Oncol 1993; 20 (5 Suppl. 6): 80-87.
11. Taylor KM, Jagannath S, Spitzer G et al. Recombinant human granulocyte colony stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 1989; 7: 1791-1799.
12. Nemunaitis J, Rabinowe SN, Singer JW et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in lymphoid cancer. New Engl J Med 1991; 324: 1773-1778.
13. Cosset JM, Socie G, Dubray B et al. Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations. Int J Radiat Oncol Biol Phys 1994; 30: 477-492.
14. Korbling M, Dorken B, Ho AD et al. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 1986; 67: 529-532.
15. Korbling M, Holle R, Haas R et al. Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J Clin Oncol 1990; 8: 978-985.
16. Reiffers J, Bernard P, David B et al. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Haematol 1986; 14: 312-315.
17. Elias AD, Mazanet R, Wheeler C et al. GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with and without bone marrow as hematologic support of high-dosed chemotherapy: two protocols. Breast Cancer Res Treat 1991; 20 (Suppl.): s25-29.
18. Anderson CC, Goldstone AH, Sounhami RL et al. Very high dose chemotherapy with autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. New Engl J Med 1987; 316: 1493-1498.
19. Cahn JY, Herve P, Flesch M et al. Autologous bone marrow transplantation (ABMT) for acute leukemia in complete remission: a pilot study of 33 cases. Br J Hematol 1986; 63: 457-470.
20. Jagannath S, Dicke KA, Armitage JO et al. High-dose cyclophosphamide, carmustine and etoposide and autologous bone marrow transplantation for relapse of Hodgkins disease. Ann Intern Med 1986; 104: 163-168.
21. Philip T, Dumont J, Teillet F et al. High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease. Br J Cancer 1986; 53: 737-742.
22. Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroxycyclophosphamide. New Engl J Med 1986; 315: 141-147.
23. Iwen PC, Reed EC, Armitage OA et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or periferal stem cell transplants. Infect Control Hosp Epidemiol 1993; 14: 131-139.
24. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668-672.
25. Goodrich JM, Reed EC, Mori M et al. Clinical features and analysis of risk factors for invasive candidal infection after bone marrow transplantation. J Infect Dis 1991; 164: 731-740.
26. Wade JC, Schimpff SC, Newman KA, Wiernik HH. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982; 97: 503-508.
27. Peterson FB, Clift RA, Hickman RO et al. Hickman catheter complications in marrow transplant recipients. J Parenter Enteral Nutr 1986; 10: 58-62.
28. Lim SH, McMillan AK, Chopra R et al. Transplant related septicaemia in patients undergoing autologous bone marrow transplantation for lymphoma and acute leukaemia. Leuk Lymphoma 1991; 5: 127-132.
29. Reed E. Infectious complications during autotransplantation. Hematol Oncol Clin North Am 1993; 7: 717-735.
30. Cometta A, Calandra T, Bille J, Glauser MP. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia (letter). New Engl J Med 1994; 330: 1240-1241.
31. Wendt CH, Weisdorf DJ, Jordan MC et al. Parainfluenza virus respiratory infection after bone marrow transplantation. New Engl J Med 1992; 326: 921-926.
32. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone-marrow transplantation. New Engl J Med 1985; 312: 529-533.
33. Carrigan DR, Drobyski WR, Russler SK et al. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991; 338: 147-149.
34. Cone RW, Hackman RC, Huang ML et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. New Engl J Med 1993; 329: 203-204.
35. Harrington RD, Hooton TM, Hackman RC et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165: 987-993.
36. Wingard JR, Chen DY, Burns WH et al. Cytomegalovirus infection after autologous bone marrow transplantation with comparison after allogeneic bone marrow transplantation. Blood 1988; 71: 1432-1437.
37. Ruesser P, Fisher LD, Buckner CD et al. Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment. Blood 1990; 75: 1888-1894.
38. Schuchter LM, Wingard JR, Piantadosi S et al. Herpes zoster infection after autologous bone marrow transplantation. Blood 1989; 74: 1424-1427.